As the Chief Executive Officer of SC1 London Life Sciences Innovation District, Georgina Rizik is at the forefront of a transformative initiative that aims to redefine the landscape of healthcare and biotechnology in the heart of London. With over 25 years of experience spanning the...
As the Chief Executive Officer of SC1 London Life Sciences Innovation District, Georgina Rizik is at the forefront of a transformative initiative that aims to redefine the landscape of healthcare and biotechnology in the heart of London. With over 25 years of experience spanning the private, public, and non-profit sectors, Georgina leverages her extensive expertise to set a visionary strategy that fosters collaboration among key stakeholders, including King’s College London and three prominent NHS Foundation Trusts: Guy’s and St Thomas’, King’s College Hospital, and South London and Maudsley.
Under her leadership, SC1 is not just a hub for innovation; it is a catalyst for change in personalized care and health equity. Georgina is passionate about driving the commercialization of groundbreaking innovations, ensuring that they translate into tangible benefits for patients and communities. Her role involves spearheading key projects that bridge the gap between academia and industry, facilitating partnerships that accelerate the development of Medtech solutions and precision medicine.
Georgina’s influential communication skills and strategic mindset enable her to effectively engage with diverse stakeholders, from startups to established enterprises, fostering an environment of mentorship and collaboration. Her commitment to planning, budgeting, and forecasting ensures that SC1 remains financially sustainable while pursuing ambitious goals. As a purpose-driven leader, Georgina Rizik is not only shaping the future of life sciences in London but is also setting a global benchmark for innovation districts, making significant strides toward a more equitable healthcare landscape.
